Quick Links: Skip to main page content
Skip to Search
Skip to Topics Menu
Skip to Common Links
U.S. Food & Drug Administration
Follow FDA
En Español
Search FDA
Home
Food
Drugs
Medical Devices
Radiation-Emitting Products
Vaccines, Blood & Biologics
Animal & Veterinary
Cosmetics
Tobacco Products
New Pediatric Labeling Information Database - Detail
FDA Home
Pediatrics
New Pediatric Labeling Information Database
Detail
-
Please note:
JavaScript must be enabled for this application to work properly.
Check your settings
if you are unsure if your JavaScript is enabled.
Pediatric Labeling Date:
01/23/2008
Trade Name:
Moxatag
Generic Name or Proper Name (*):
amoxicillin
Indications Studied:
Use for tonsillitis and/or pharyngitis secondary to Streptococcus pyogenes patients 12 years of age and older
Label Changes Summary:
Safety and effectiveness in pediatric patients younger than 12 years have not been established One clinical study evaluated safety and effectiveness in pediatric patients 12 years of age and older with no significant differences in treatment response or adverse reactions between adults and children A prospective study of 51 children suggested that overdosages of less than 250 mg/kg are not associated with significant clinical symptoms and do not require gastric emptying Waiver of studies in children ages 0 to less than two years because too few children have the disease New dosage form
Product Labeling:
Labeling
PREA(P):
P
Sponsor:
Middlebrook Pharmaceuticals
NNPS:
FALSE'
Therapeutic Category:
Antibiotic
-
-